Play

Pfizer has asked the FDA to approve its new oral medication for Covid-19, called Paxlovid, for people in the early stages of infection. Brian Garibaldi, a critical care medicine expert at Johns Hopkins, reviews the data. Garibaldi: From symptom onset …

What do we know about the new oral medicine from Pfizer for Covid? Elizabeth Tracey reports Read more »

Play

It stands to reason that people with cancer might be more susceptible to developing severe Covid-19 disease, and now a new analysis confirms it. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, describes the data. Nelson: It …

If you have cancer, is Covid-19 disease worse? Elizabeth Tracey reports Read more »

Play

Children under twelve remain at risk for Covid infection, and even older children who can’t receive the vaccine or are immunocompromised are also at risk. Anna Durbin, an infectious disease expert at Johns Hopkins, says there are steps parents can …

How should parents protect their children who aren’t vaccinated against Covid-19? Elizabeth Tracey reports Read more »

Play

Mu is just the latest Covid-19 variant that’s drawing the attention of many, with potentially worrisome mutations that may predict how infectious it might be.  Anna Durbin, an infectious disease expert at Johns Hopkins, says current vaccines should still provide pretty …

What do we know about the Covid variant called mu? Elizabeth Tracey reports Read more »

Play

When enough people in certain geographic areas choose not to be vaccinated against viral diseases, outbreaks happen. We’ve been seeing this nationally with measles for years, and Covid-19 is no exception. Anna Durbin, an infectious disease expert at Johns Hopkins, …

With so many people vaccinated against Covid, why do surges keep happening? Elizabeth Tracey reports Read more »

Play

The mu variant of Covid-19 is spreading, with new variants cropping up all the time. Anna Durbin, an infectious disease expert at Johns Hopkins, says although variants are concerning, the beauty of mRNA vaccines is the ease with which new …

How quickly will Covid vaccines be able to be made against variants? Elizabeth Tracey reports Read more »

Play

The best strategy to mitigate Covid-19 infection is still prevention with vaccines, but if you develop the disease, new oral medicines are poised to take their place in treatment. Mark Sulkowski, an infectious disease expert at Johns Hopkins, explains. Sulkowski: …

Are oral medicines for Covid-19 on the horizon? Elizabeth Tracey reports Read more »